Organization | Baqai Medical University

Baqai Medical University Report issue

Academic/Hospital Phase 4

Organization Overview

First Clinical Trial

2012

NCT02737423

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2022

Timeline

NOW

Alternative names

Baqai Institute of Diabetology and Endocrinology | Baqai Institute of Diabetology and Endocrinology, Baqai Medical University | Baqai Institute of Diabetology and Endocrinology (BIDE) | Baqai Medical University

Active Ingredients

Drugs in Phase 4 Trials (4)

diclofenac (voltaren) (1 trial)

piroxicam (feldene) (1 trial)

tramadol (Ultram) (1 trial)

vitamin e (1 trial)

Drugs in Other Trials (4)

lead acetate (1 trial)

moringa (1 trial)

pisum sativum whole (1 trial)

vitamin d3 (2 trials)

Indications

Overview

Highest Phase: Phase 4
# of Trials: 4
# of Trial APIs: 8